Squarepoint Ops LLC Aerovate Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.41 - $30.75 $80,485 - $1.76 Million	57,082 New	57,082 $94,000
Q1 2022 May 16, 2022	SELL	$8.25 - $18.33 $106,763 - $237,208	-12,941 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.14 - $21.54 $118,280 - $278,749	12,941 New	12,941 $153,000
Q3 2021 Nov 15, 2021	SELL	$11.76 - $22.49 $105,840 - $202,410	-9,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.83 - $22.83 $205,469 - $205,469	9,000 New	9,000 $205,000

28.1M

116K

26.6K

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $64.3M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.